Moderna's Covid-19 vaccine would not have scaled without Ginkgo Bioworks. Reshma Shetty, co-founder and COO of Ginkgo – slated to go public via SPAC acquisition at a reported $15 billion valuation – explains how biotech innovation can build a better future now. Ginkgo's platform already serves industries from food and agriculture, to materials, to healthcare. Shetty acknowledges that engineering genes is a high stakes pursuit, and says Ginkgo is trying to pair the ambition of Silicon Valley with a "higher level of care" than consumer tech companies like social media have demonstrated. The key, Shetty says, is creating an unstable equilibrium – propelling progress but not at the expense of principles. Read a transcript of this episode at: https://mastersofscale.com Subscribe to the Masters of Scale weekly newsletter at https://mastersofscale.com/subscribe See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How do you win the post-pandemic war for talent? Send your frontline workers to online school. That's the pitch that Rachel Carlson has made – successfully – to big businesses from Chipotle to Disney, Walmart to Waste Management. As co-founder and CEO of Guild Education, Carlson runs a digital platform that enables workers to get degrees and certifications as a free employee benefit. Though virtual schooling for kids is under fire, virtual education for adults has caught on over the last year like never before. To meet the ongoing need for “upskilling” in the modern economy, Carlson says, company-sponsored digital classes should be as ubiquitous as company-sponsored health plans. The ROI, she explains, is astonishingly high. Read a transcript of this episode at: https://mastersofscale.com Subscribe to the Masters of Scale weekly newsletter at https://mastersofscale.com/subscribe See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.